Encompass Health Corporation (EHC)

$99.4

+0.47

(+0.48%)▲

Market is closed - opens 8 PM, 22 Nov 2024

Performance

  • $98.09
    $99.55
    $99.40
    downward going graph

    1.32%

    Downside

    Day's Volatility :1.47%

    Upside

    0.15%

    downward going graph
  • $63.78
    $104.55
    $99.40
    downward going graph

    35.84%

    Downside

    52 Weeks Volatility :39.0%

    Upside

    4.93%

    downward going graph

Returns

PeriodEncompass Health CorporationSector (Health Care)Index (Russel 2000)
3 Months
10.57%
-6.9%
0.0%
6 Months
16.46%
-1.7%
0.0%
1 Year
50.47%
10.4%
0.0%
3 Years
57.53%
8.8%
-24.1%

Highlights

Market Capitalization
10.0B
Book Value
$19.44
Dividend Share
0.62
Dividend Yield
0.69%
Earnings Per Share (EPS)
4.25
PE Ratio
23.39
Wall Street Target Price
115.25
Profit Margin
8.1%
Operating Margin TTM
15.48%
Return On Assets TTM
8.38%
Return On Equity TTM
22.92%
Revenue TTM
5.2B
Revenue Per Share TTM
52.26
Quarterly Revenue Growth YOY
11.899999999999999%
Gross Profit TTM
1.8B
EBITDA
1.1B
Diluted Eps TTM
4.25
Quarterly Earnings Growth YOY
0.26
EPS Estimate Current Year
4.3
EPS Estimate Next Year
4.78
EPS Estimate Current Quarter
0.94
EPS Estimate Next Quarter
1.01

Analyst Recommendation

Buy
    93%Buy
    6%Hold
    0
    0%Sell
Based on 15 Wall street analysts offering stock ratings for Encompass Health Corporation(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
13
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 15.95%

Current $99.40
Target $115.25

Company Financials

FY18Y/Y Change
Revenue
4.3B
↑ 9.14%
Net Income
292.3M
↑ 14.05%
Net Profit Margin
6.83%
↑ 0.29%
FY19Y/Y Change
Revenue
4.6B
↑ 7.66%
Net Income
358.7M
↑ 22.72%
Net Profit Margin
7.79%
↑ 0.96%
FY20Y/Y Change
Revenue
4.6B
↑ 0.86%
Net Income
284.2M
↓ 20.77%
Net Profit Margin
6.12%
↓ 1.67%
FY21Y/Y Change
Revenue
5.1B
↑ 10.27%
Net Income
412.2M
↑ 45.04%
Net Profit Margin
8.05%
↑ 1.93%
FY22Y/Y Change
Revenue
4.3B
↓ 15.09%
Net Income
271.0M
↓ 34.26%
Net Profit Margin
6.23%
↓ 1.82%
FY23Y/Y Change
Revenue
4.8B
↑ 10.41%
Net Income
352.0M
↑ 29.89%
Net Profit Margin
7.33%
↑ 1.1%
Q2 FY23Q/Q Change
Revenue
1.2B
↑ 2.3%
Net Income
91.4M
↑ 4.22%
Net Profit Margin
7.7%
↑ 0.14%
Q3 FY23Q/Q Change
Revenue
1.2B
↑ 1.67%
Net Income
85.3M
↓ 6.67%
Net Profit Margin
7.07%
↓ 0.63%
Q4 FY23Q/Q Change
Revenue
1.2B
↑ 3.31%
Net Income
87.6M
↑ 2.7%
Net Profit Margin
7.03%
↓ 0.04%
Q1 FY24Q/Q Change
Revenue
1.3B
↑ 5.55%
Net Income
112.5M
↑ 28.42%
Net Profit Margin
8.55%
↑ 1.52%
Q2 FY24Q/Q Change
Revenue
1.3B
↓ 1.12%
Net Income
114.1M
↑ 1.42%
Net Profit Margin
8.77%
↑ 0.22%
Q3 FY24Q/Q Change
Revenue
1.4B
↑ 3.83%
Net Income
108.2M
↓ 5.17%
Net Profit Margin
8.01%
↓ 0.76%
FY18Y/Y Change
Total Assets
5.2B
↑ 6.82%
Total Liabilities
3.4B
↑ 3.33%
FY19Y/Y Change
Total Assets
6.1B
↑ 16.32%
Total Liabilities
4.1B
↑ 23.59%
FY20Y/Y Change
Total Assets
6.4B
↑ 6.01%
Total Liabilities
4.4B
↑ 7.14%
FY21Y/Y Change
Total Assets
6.9B
↑ 6.5%
Total Liabilities
4.5B
↑ 0.48%
FY22Y/Y Change
Total Assets
5.6B
↓ 17.89%
Total Liabilities
3.8B
↓ 15.48%
FY23Y/Y Change
Total Assets
6.1B
↑ 8.27%
Total Liabilities
3.8B
↑ 0.81%
Q2 FY23Q/Q Change
Total Assets
5.9B
↑ 1.98%
Total Liabilities
3.8B
↑ 0.52%
Q3 FY23Q/Q Change
Total Assets
6.0B
↑ 1.76%
Total Liabilities
3.8B
↓ 0.76%
Q4 FY23Q/Q Change
Total Assets
6.1B
↑ 2.32%
Total Liabilities
3.8B
↑ 0.8%
Q1 FY24Q/Q Change
Total Assets
6.2B
↑ 2.11%
Total Liabilities
3.8B
↑ 0.6%
Q2 FY24Q/Q Change
Total Assets
6.4B
↑ 2.52%
Total Liabilities
3.9B
↑ 0.8%
Q3 FY24Q/Q Change
Total Assets
6.5B
↑ 1.09%
Total Liabilities
3.7B
↓ 3.26%
FY18Y/Y Change
Operating Cash Flow
762.4M
↑ 16.01%
Investing Cash Flow
-424.5M
↑ 49.21%
Financing Cash Flow
-321.2M
↓ 10.75%
FY19Y/Y Change
Operating Cash Flow
635.3M
↓ 16.67%
Investing Cash Flow
-657.4M
↑ 54.86%
Financing Cash Flow
48.2M
↓ 115.01%
FY20Y/Y Change
Operating Cash Flow
704.7M
↑ 10.92%
Investing Cash Flow
-407.5M
↓ 38.01%
Financing Cash Flow
-145.9M
↓ 402.7%
FY21Y/Y Change
Operating Cash Flow
715.8M
↑ 1.58%
Investing Cash Flow
-666.3M
↑ 63.51%
Financing Cash Flow
-240.1M
↑ 64.56%
FY22Y/Y Change
Operating Cash Flow
705.8M
↓ 1.4%
Investing Cash Flow
-627.0M
↓ 5.9%
Financing Cash Flow
-145.7M
↓ 39.32%
Q2 FY23Q/Q Change
Operating Cash Flow
206.7M
↓ 9.3%
Investing Cash Flow
-128.5M
↑ 23.56%
Financing Cash Flow
-43.5M
↓ 25.0%
Q3 FY23Q/Q Change
Operating Cash Flow
215.2M
↑ 4.11%
Investing Cash Flow
-394.7M
↑ 207.16%
Financing Cash Flow
-65.8M
↑ 51.26%

Technicals Summary

Sell

Neutral

Buy

Encompass Health Corporation is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Encompass Health Corporation
Encompass Health Corporation
4.09%
16.46%
50.47%
57.53%
40.34%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
5.22%
5.42%
11.35%
-29.42%
-40.21%
Hca Holdings, Inc.
Hca Holdings, Inc.
-18.6%
4.34%
31.31%
38.19%
138.68%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
-5.93%
13.42%
118.4%
88.34%
370.63%
Universal Health Services Inc.
Universal Health Services Inc.
-15.02%
10.46%
42.8%
55.32%
41.84%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
0.6%
21.81%
65.0%
59.87%
126.46%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Encompass Health Corporation
Encompass Health Corporation
23.39
23.39
NA
4.3
0.23
0.08
0.01
19.44
Fresenius Medical Care Ag
Fresenius Medical Care Ag
18.31
18.31
0.44
2.23
0.06
0.03
0.03
46.43
Hca Holdings, Inc.
Hca Holdings, Inc.
14.95
14.95
1.07
21.97
0.12
0.12
0.01
-8.57
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
4.69
4.69
0.7
11.2
0.6
0.07
NA
40.32
Universal Health Services Inc.
Universal Health Services Inc.
13.17
13.17
1.87
15.95
0.16
0.07
0.0
100.14
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
17.39
17.39
1.22
9.74
0.45
0.07
NA
4.68
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Encompass Health Corporation
Encompass Health Corporation
Buy
$10.0B
40.34%
23.39
8.1%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$13.0B
-40.21%
18.31
3.43%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$84.3B
138.68%
14.95
8.52%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$14.1B
370.63%
4.69
14.91%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$13.0B
41.84%
13.17
6.66%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$13.2B
126.46%
17.39
6.53%

Insights on Encompass Health Corporation

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.30B → 1.35B (in $), with an average increase of 3.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 114.1M → 108.2M (in $), with an average decrease of 5.2% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 118.4% return, outperforming this stock by 67.9%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 88.3% return, outperforming this stock by 30.8%

Institutional Holdings

  • Vanguard Group Inc

    10.19%

  • BlackRock Inc

    8.98%

  • Wellington Management Company LLP

    6.84%

  • Amvescap Plc.

    5.05%

  • William Blair Investment Management, LLC

    3.28%

  • State Street Corp

    2.98%

Corporate Announcements

  • Encompass Health Corporation Dividends March,2025

    In the quarter ending March,2025. Encompass Health Corporation has declared dividend of $0.17

    Read More

Company Information

as a national leader of post-acute care, encompass health offers facility-based and home-based patient care through our network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. we are committed to delivering high-quality, cost-effective care across the post-acute continuum. driven by a set of shared values, encompass health is the result of the union between healthsouth corporation and encompass home health & hospice.our approach to post-acute care sets us apart. we firmly believe that every success starts with our dedicated team of professionals, so we make sure they are empowered with the tools they need to help our patients be successful. innovative technologies, advanced therapies, customized treatment plans, coordinated care teams – these are all part of our promise to deliver the highest level of care.

Organization
Encompass Health Corporation
Employees
27481
CEO
Mr. Mark J. Tarr
Industry
Health Services

FAQs